NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 30 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,466 | +58447.8% | 149,612 | +59744.8% | 0.00% | – |
Q2 2023 | $23 | -11.5% | 250 | +150.0% | 0.00% | – |
Q1 2023 | $26 | +23.8% | 100 | 0.0% | 0.00% | – |
Q4 2022 | $21 | – | 100 | -4.8% | 0.00% | – |
Q3 2022 | $0 | – | 105 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 105 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 105 | -98.9% | 0.00% | – |
Q4 2021 | $9,000 | 0.0% | 9,371 | +76.9% | 0.00% | – |
Q3 2021 | $9,000 | -25.0% | 5,298 | -22.2% | 0.00% | – |
Q2 2021 | $12,000 | +140.0% | 6,810 | +153.5% | 0.00% | – |
Q1 2021 | $5,000 | +150.0% | 2,686 | +229.2% | 0.00% | – |
Q4 2020 | $2,000 | -60.0% | 816 | -54.3% | 0.00% | – |
Q3 2020 | $5,000 | – | 1,785 | +1600.0% | 0.00% | – |
Q2 2020 | $0 | – | 105 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 105 | +2000.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 5 | -99.9% | 0.00% | – |
Q3 2019 | $3,000 | – | 4,681 | +4358.1% | 0.00% | – |
Q2 2019 | $0 | – | 105 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
UBS Group AG | 1,785 | $5,000 | 0.00% |